PARIS (Reuters) - Sanofi said on Monday it had entered exclusive negotiations for the sale of a 50% controlling stake in its ...

Sanofi entered into exclusive talks to sell its consumer-healthcare business Opella to Clayton Dubilier & Rice in a deal that ...

Clayton Dubilier & Rice is nearing a deal to acquire control of Sanofi’s consumer health unit after the American buyout firm ...

Sanofi on Sunday reached an agreement on terms to sell a controlling stake in its consumer health unit Opella to U.S. private ...

Sanofi is aiming to sign an agreement this weekend to sell control of its consumer health business to Clayton Dubilier & Rice ...

Deal for consumer health arm has faced a political backlash over ceding controlling stake to American private equity group ...

France's CGT and CFDT unions have called on workers at pharma company Sanofi to strike from Thursday to show their protest ...

Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare Sanofi and CD&R enter exclusive negotiations to transfer a 50% controlling stake in Opella with Sanofi to remain a significant ...

The gift will be spread over 10 years and divided among Morehouse, Howard University College of Medicine and Meharry Medical ...

The French government needs guarantees from drugmaker Sanofi that production of its popular Doliprane painkiller will stay in ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Clayton Dubilier & Rice is set to buy Sanofi's consumer health unit with social commitments, including job creation ...